Imaging businesses that are having a hard time covering costs amid widespread drops in patient visits may have a lifeline, thanks to recently passed legislation. 

Two radiologists reflect on what went wrong AI-wise with the Boeing 737 MAX, outlining potential parallels between aviation and their specialty. 

Venture capital firm General Catalyst and other investors are sinking $51 million into Columbus, Ohio-based Olive with the aim of growing the AI startup’s capacity for automating administrative processes in healthcare.

The advanced and accelerated payment offering applies to all docs who accept Medicare, and is part of the recently signed CARES Act. 

The tech sector is abuzz with high hopes in AI’s potential to help the world beat back COVID-19. A veteran writer who’s been on the high-tech beat for years offers a reality check.

In a statement sent to Radiology Business, the college said it looks forward to “swift regulatory action” that will spell out how imaging practices and hospitals can apply for relief.

The stakes are high in the fight, with estimates that the Bloomfield, Connecticut, practice could rake in upward of $2 million annually with the addition. 

The Florida-based company said that imaging orders are falling short of past historical levels, with much of the reduction tied to nonurgent care.